Role of Opioids and Complements in AIDS Pathogenesis

阿片类药物和补体在艾滋病发病机制中的作用

基本信息

  • 批准号:
    7781399
  • 负责人:
  • 金额:
    $ 10.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-03-01 至 2012-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal is for a three year mentored research award at the Center for Neurovirology, Temple University for the development of a career in AIDS pathogenesis. The principal investigator will expand upon his skills and solicits further training in field of AIDS research and drug abuse prior to independent research in the field of AIDS. The long-term goal of this research is to define the mechanism(s) of regulation and role of the complement system in the pathogenesis of neuroAIDS and HIVAN and the potentiating role of drugs of abuse. HIV and HTLV are unique in their resistance to complement mediated virolysis. HIV-specific antibodies augment both activation and deposition of complement components as C3 and C5 on virions thus protecting them from neutralizing antibodies and the same time enhance infection of macrophages through complement receptors. In view of these properties, complement may facilitate virus transmission, dissemination within the host, and contribute to evasion of immune system. Furthermore, complement proteins activated by HIV have pro-inflammatory and chemotactic properties relevant to the pathogenesis of both NeuroAIDS and HIVAN. Inhibition of complement synthesis and activation may represent a putative therapeutic goal to prevent virus-induced damage. Our preliminary studies indicate that inflammatory cytokines, and C/EBP-beta and delta activate C3 promoter. Overexpression of dominant negative p38alpha or MKK6 attenuates C3 promoter activity, while morphine stimulates cytokine induced C3 expression. We hypothesize that opiates may play a detrimental role in the pathogenesis of NeuroAIDS and HIVAN by inducing C3 expression via upregulation of MKK6 and p38 MAPK activity which in turn modulates C/EBP's, the critical player in C3 promoter activation. The proposed studies will elucidate the molecular mechanism of complement activation by host proteins, and the effects of opioids on complement activation in in vitro ceil culture systems and in a rhesus macaque model of simian immunodeficiency virus (SIV) infection. Dr. Jay Rappaport, an expert in NeuroAIDS, will mentor the Pi's scientific development. To enhance the training, the program will include Dr. Thomas J. Rogers, expert in opioid receptor biology. The results of these studies will facilitate a better understanding of the mechanisms of complement-mediated injury in HIV infection and drug abuse, and serve as an effective training/mentoring mechanism for the PI.
描述(由申请人提供):该提案是在坦普尔大学神经病毒学中心的三年指导研究奖,以开发艾滋病发病机理的职业。首席研究者将在艾滋病领域进行独立研究之前,扩大他在艾滋病研究和药物滥用领域进行进一步培训的技能和寻求。这项研究的长期目标是确定补体系统在神经辅助和Hivan的发病机理中的调节和作用机制,以及滥用药物的增强作用。艾滋病毒和HTLV在抵抗介导的毒化方面是独一无二的。 HIV特异性抗体增强了补体成分的激活和沉积为C3和C5在病毒体上,从而保护它们免受中和抗体的影响,同时通过补体受体增强了巨噬细胞的感染。鉴于这些特性,补体可以促进病毒传播,宿主内部传播,并有助于逃避免疫系统。此外,由HIV激活的补体蛋白具有与神经辅助和Hivan的发病机理有关的促炎和趋化特性。抑制补体合成和激活可能代表了预防病毒诱导损伤的假定治疗目标。我们的初步研究表明,炎性细胞因子,C/EBP-beta和Delta激活C3启动子。显性负P38Alpha或MKK6的过表达减弱了C3启动子活性,而吗啡刺激细胞因子诱导的C3表达。我们假设阿片类药物可能通过上调MKK6和p38 MAPK活性来诱导C3表达在神经辅助和Hivan的发病机理中发挥有害作用,从而调整C3启动子激活中的关键参与者C/EBP。拟议的研究将阐明宿主蛋白补体激活的分子机制,以及阿片类药物对体外CEIL培养系统中补体激活的影响以及邻肌免疫缺陷病毒(SIV)感染的恒河猴猕猴模型。神经辅助专家Jay Rappaport博士将指导PI的科学发展。为了增强培训,该计划将包括阿片受体生物学专家Thomas J. Rogers博士。这些研究的结果将有助于更好地理解艾滋病毒感染和药物滥用中补体介导的损伤的机制,并作为PI的有效培训/指导机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Prasun K Datta其他文献

Prasun K Datta的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Prasun K Datta', 18)}}的其他基金

Periodontitis as a comorbidity in SIV infection and Antiretroviral Therapy
牙周炎作为 SIV 感染和抗逆转录病毒治疗的合并症
  • 批准号:
    10548688
  • 财政年份:
    2022
  • 资助金额:
    $ 10.71万
  • 项目类别:
Role of epigenetics in glutamate transporter EAAT2regulation in neuroaids
表观遗传学在神经辅助谷氨酸转运蛋白 EAAT2 调节中的作用
  • 批准号:
    8652965
  • 财政年份:
    2011
  • 资助金额:
    $ 10.71万
  • 项目类别:
Role of epigenetics in glutamate transporter EAAT2regulation in neuroaids
表观遗传学在神经辅助谷氨酸转运蛋白 EAAT2 调节中的作用
  • 批准号:
    8843821
  • 财政年份:
    2011
  • 资助金额:
    $ 10.71万
  • 项目类别:
Role of epigenetics in glutamate transporter EAAT2regulation in neuroaids
表观遗传学在神经辅助谷氨酸转运蛋白 EAAT2 调节中的作用
  • 批准号:
    8140874
  • 财政年份:
    2011
  • 资助金额:
    $ 10.71万
  • 项目类别:
Role of epigenetics in glutamate transporter EAAT2regulation in neuroaids
表观遗传学在神经辅助谷氨酸转运蛋白 EAAT2 调节中的作用
  • 批准号:
    8854538
  • 财政年份:
    2011
  • 资助金额:
    $ 10.71万
  • 项目类别:
Role of epigenetics in glutamate transporter EAAT2regulation in neuroaids
表观遗传学在神经辅助谷氨酸转运蛋白 EAAT2 调节中的作用
  • 批准号:
    8453476
  • 财政年份:
    2011
  • 资助金额:
    $ 10.71万
  • 项目类别:
Role of epigenetics in glutamate transporter EAAT2regulation in neuroaids
表观遗传学在神经辅助谷氨酸转运蛋白 EAAT2 调节中的作用
  • 批准号:
    8293112
  • 财政年份:
    2011
  • 资助金额:
    $ 10.71万
  • 项目类别:
Role of epigenetics in glutamate transporter EAAT2regulation in neuroaids
表观遗传学在神经辅助谷氨酸转运蛋白 EAAT2 调节中的作用
  • 批准号:
    9066273
  • 财政年份:
    2011
  • 资助金额:
    $ 10.71万
  • 项目类别:
Role of Opioids and Complements in AIDS Pathogenesis
阿片类药物和补体在艾滋病发病机制中的作用
  • 批准号:
    7579934
  • 财政年份:
    2008
  • 资助金额:
    $ 10.71万
  • 项目类别:
Role of Opioids and Complements in AIDS Pathogenesis
阿片类药物和补体在艾滋病发病机制中的作用
  • 批准号:
    7422471
  • 财政年份:
    2008
  • 资助金额:
    $ 10.71万
  • 项目类别:

相似海外基金

Interactions of Alcohol and Pain in the Context of HIV
艾滋病毒背景下酒精和疼痛的相互作用
  • 批准号:
    10762596
  • 财政年份:
    2023
  • 资助金额:
    $ 10.71万
  • 项目类别:
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"
加巴喷丁减少饮酒并改善病毒载量抑制——促进“治疗即预防”
  • 批准号:
    10706554
  • 财政年份:
    2022
  • 资助金额:
    $ 10.71万
  • 项目类别:
Effects of Auditory Neuropathy and Cochlear Hearing Loss on Speech Perception
听觉神经病变和耳蜗听力损失对言语感知的影响
  • 批准号:
    10458872
  • 财政年份:
    2022
  • 资助金额:
    $ 10.71万
  • 项目类别:
Cellular and circuitry mechanisms of NRTI-induced pain pathogenesis in the context of opioids and HIV
阿片类药物和 HIV 背景下 NRTI 诱导的疼痛发病机制的细胞和电路机制
  • 批准号:
    10559782
  • 财政年份:
    2022
  • 资助金额:
    $ 10.71万
  • 项目类别:
Effects of Auditory Neuropathy and Cochlear Hearing Loss on Speech Perception
听觉神经病变和耳蜗听力损失对言语感知的影响
  • 批准号:
    10577419
  • 财政年份:
    2022
  • 资助金额:
    $ 10.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了